Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Filings indexed 1,623 across all filing types
Latest filing 2025-12-02 Regulatory Filings
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority
Regulatory Filings
2025-12-02 Danish
Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority
Audit Report / Information Classification · 1% confidence The document is a formal company announcement issued in response to a regulatory order from the Danish Business Authority regarding accounting corrections (IFRS 9 ECL model application) for previously published financial reports (Annual Report 2024 and Interim Report H1 2025). While it contains financial tables, it is not the report itself but an announcement of corrective information and a pending audit supplement. It does not fit into specific categories like 10-K or IR as it is a corrective disclosure, and it is not a simple 'report publication announcement' because it provides substantive financial data and explanations of the accounting changes. Therefore, it is best classified as a Regulatory Filing (RNS). H1 2025
2025-12-02 English
Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority
Regulatory Filings
2025-12-02 Danish
Legal Proceedings Report 2025
Legal Proceedings Report Classification · 1% confidence The document is a corporate announcement regarding regulatory approval for a clinical trial (RNX-011). It is labeled as a 'Selskabsmeddelelse' (Company Announcement) and explicitly mentions it is a correction of a previous announcement to ensure it is filed under the correct regulatory category ('Intern viden'). Since it is a general regulatory announcement regarding company operations and clinical milestones that does not fit into specific categories like financial reports or shareholder voting, it is classified as a Regulatory Filing (RNS).
2025-09-02 Danish
Regulatory Filings 2025
Regulatory Filings Classification · 1% confidence The document is a corporate announcement regarding regulatory approval for a clinical trial (RNX-011). It is titled 'Selskabsmeddelelse nr. 10' (Company Announcement no. 10), which is a standard format for regulatory disclosures in Denmark. Since it does not fit into specific categories like financial reports, dividends, or board changes, and serves as a general corporate update/announcement, it falls under the 'Regulatory Filings' (RNS) category.
2025-09-02 Danish
Regulatory Filings 2025
Regulatory Filings Classification · 1% confidence The document is a company announcement regarding regulatory approval for a clinical trial. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement (RPA) as it provides the actual news content rather than just announcing the availability of a report. Since it is a general corporate announcement regarding business operations and regulatory milestones that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2025-09-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.